🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

11 recruiting trials

for Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type

Sintilimab With P-GEMOX Versus the P-GEMOX in the Teatment of Advanced-stage Extranodal Natural Killer/T Cell Lymphoma NCT06583083Phase 21 site📍 Guangzhou Sun Yat-sen University · Tests: Sintilimab with P-GEMOX Regimen, P-GEMOX Regimen A Prospective Clinical Study on Reduced-intensity Radiotherapy for Stage I/II Low-risk Nasal-type NK/T-cell Lymphoma Achieving Complete Remission After Chemotherapy NCT07628738Phase 21 site📍 Shanghai Ruijin Hospital · Tests: reduced-intensity radiotherapy Screening Study of Combined Sequential Chemotherapy and Radiation Therapy for Early-stage NK/T-cell Lymphoma NCT06314334Phase 27 sites📍 Fuzhou📍 Nantong📍 Shanghai Fudan University · Tests: Sintilimab+Pegaspargase, P-GemOx, GELAD, IMRT Linperlisib Combined With Camrelizumab and Pegaspargase in Advanced or Relapsed/Refractory NK/T-cell Lymphoma NCT06376721Phase 1, Phase 21 site📍 Beijing Beijing Tongren Hospital · Tests: Linperlisib, Camrelizumab, Pegaspargase, Dexamethasone A Registry for People With T-cell Lymphoma NCT05978141n/a26 sites📍 Duarte📍 San Diego📍 San Francisco Memorial Sloan Kettering Cancer Center · Tests: Optional Blood Sample and Nail Sample PD-1 Antibody-based Therapy With Concurrent RT for Early-stage NKTCL NCT07380984Phase 21 site📍 Shanghai Ruijin Hospital · Tests: PD-1 antibody, radiotherapy, Chidamide, golidocitinib Concurrent Tislelizumab and Radiotherapy in Newly Diagnosed Extranodal NK/T-cell Lymphoma, Nasal Type NCT05477264Phase 21 site📍 Seoul Won Seog Kim · Tests: Tislelizumab PET and EBV DNA-directed Therapy for Localized Nasal Extranodal NK/T Cell Lymphoma NCT06069830NA1 site📍 Shanghai Ruijin Hospital · Tests: 4 cycles of ESA regimen with sandwiched radiotherapy, 2 cycles of ESA regimen sequential radiotherapy and 2 cycles of P… Registry of Older Patients With Cancer NCT01137825n/a7 sites📍 Boone📍 Chapel Hill📍 Greenville UNC Lineberger Comprehensive Cancer Center Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer NCT01137643n/a1 site📍 Chapel Hill UNC Lineberger Comprehensive Cancer Center · Tests: biologic sample preservation procedure, cytology specimen collection procedure A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas NCT05475925Phase 1, Phase 237 sites📍 Birmingham📍 Duarte📍 Irvine Dren Bio · Tests: DR-01
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy